Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

Diabetes Issues Author: Staff Last Updated: Aug 21, 2007 - 8:28:33 PM



World’s Top Diabetes Scientists to Convene in Seattle to Launch International Alliance
By Staff
Aug 21, 2007 - 8:21:55 PM

Email this article
 Printer friendly page
World’s Top Diabetes Scientists to Convene in Seattle to Launch International Alliance to fight global diabetes epidemic

Alliance to focus on clinical research of underserved populations

(HealthNewsDigest.com) - SEATTLE – More than 100 of the world's foremost diabetes experts from more than 20 countries and six continents will meet in Seattle this October to develop an ambitious clinical research agenda to address the prevention, treatment, and cure of diabetes. To spearhead the effort, the scientists will launch the first-ever global alliance focusing on the clinical research of diabetes in indigenous, disproportionately-impacted and underserved populations throughout the world.

“Diabetes is a worldwide epidemic growing at alarming rates,” said Dr. Paul Robertson, incoming President-Elect of the American Diabetes Association and President and Scientific Director of the Pacific Northwest Research Institute (PNRI), which is convening the Magnuson Congress for a Global Diabetes Alliance, named for U.S. Senator Warren G. Magnuson – a co-founder of PNRI, who died of complications from diabetes in 1989. The Congress will be held at Seattle Bell Harbor International Conference Center on October 22-23, 2007. Congress participants will include top experts from the biomedical and social sciences, as well as public health and pharmaceutical fields.

“The response from top experts from around the world to develop a global, multidisciplinary, collaborative endeavor focused on clinical research on diabetes has been overwhelming,” Robertson said. “Everyone recognizes the pressing need to expand clinical research of diabetes, especially in populations that are disproportionately impacted by the disease but not typically included in research. This approach will extend clinical research to areas of the world in need and broaden our knowledge of the causes and manifestations of diabetes overall. This will lead to greater insights into the disease and better approaches to its prevention and treatment.”

“The need for an international, collaborative alliance focused on clinical research to help curb the disease could not be more urgent,” said Pierre Lefèbvre of Belgium, immediate past president of the International Diabetes Federation (IDF) and an invited speaker at the Magnuson Congress.

The key goal of the Congress will be to outline a collaborative, multidisciplinary scientific research agenda with a particular focus on underserved populations. The agenda will help guide the formation of a global diabetes alliance. The Alliance’s first priority after its launch will be to raise the funds necessary to implement the research agenda.

“There’s a huge need to look at minority and developing country populations that haven’t traditionally been included in research,” Lefèbvre added. “Diabetes has been long perceived as a disease of affluence. However, diabetes is spreading most rapidly in poorer countries.”

According to the World Health Organization (WHO), seven out of the top 10 countries with the largest diabetic populations are located in the developing world. Countries such as India and China with the largest populations of people with diabetes are experiencing rapid increases in the prevalence of the disease. Currently, 31 million people in India and 20 million people in China have diabetes. By 2030 these numbers are projected to jump to 79 million people in India and 42 million people in China.

Worldwide, more than 180 million people have diabetes, and this figure is estimated to more than double within 30 years. In 2007, the world is estimated to spend at least $232 billion to treat and prevent diabetes and its complications, according to the IDF. By 2025, this lower-bound estimate will exceed $302.5 billion. Without urgent action, the WHO projects that diabetes deaths will increase by more than 50 percent in the next 10 years

Confirmed Congress participants to date include some of the world’s foremost diabetes experts and scientists from around the world, such as:

Professor Paul Zimmet, Director and CEO of the International Diabetes Institute, Melbourne
Professor Sir George Alberti, President of the British Government's National Clinical Director for Emergency Access
Dr. Stewart B. Harris, Professor at the Centre for Studies in Family Medicine/Department of Family Medicine, University of Western Ontario
Dr. Ann Albright, Director of the U.S. Center for Disease Control’s division of diabetes translation
Dr. Juliana Chan, Professor of Medicine and Therapeutics at the Chinese University of Hong Kong, the Prince of Wales Hospital, Shatin, Hong Kong

About the Warren G. Magnuson Congress for a Global Diabetes Alliance

The Congress is named after the late U.S. Senator Warren G. Magnuson, who represented Washington State in the U.S. Senate longer than anyone else in history. Throughout his tenure, Senator Magnuson was committed to innovative health policy. One of the first bills introduced by Senator Magnuson led to the foundation of the National Institute of Health (NIH). Senator Magnuson also secured millions of dollars in federal appropriations to support the NIH and helped to establish the Pacific Northwest Research Institute (previously known as the Pacific Northwest Research Foundation). The Magnuson Congress aims to create a scientific research agenda emphasizing clinical research on diabetes. Congress participants will discuss and select research projects that will provide data that translate into improved diabetes prevention and care for underserved populations disproportionately affected by diabetes worldwide. The Congress will launch a global diabetes alliance to secure funding for and oversee the research agenda. The Magnuson Congress is supported by funding from the U.S. Congress. For more information please visit www.pnri.org/news/2007/magnuson/.

About PNRI

PNRI is a 50 year-old independent non-profit biomedical and clinical research center located in Seattle and founded by Dr. William Hutchinson, Sr., who also founded the Fred Hutchinson Cancer Research Center. The mission of PNRI is to support and conduct basic and clinical studies that lead to the prevention and cure of diabetes and its complications. PNRI's acclaimed team of 85 doctors and researchers is committed to applying scientific discoveries to the real improvement of health for people and families living with diabetes. For more information on PNRI and diabetes, please visit www.pnri.org.

www.HealthNewsDigest.com

Top of Page

HealthNewsDigest.com

Diabetes Issues
Latest Headlines


+ Every Family Has Secrets! Could Diabetes Be One Of Them?
+ The Heart-Smart Diabetes Kitchen
+ Diabetes - This Indicator May Surprise You
+ Pharmacists Improve Care of Diabetics While Cutting Costs
+ FDA-approved Drug May Slow Beta Cell Destruction in Type 1 Diabetes Patients
+ Highest Rates of Obesity, Diabetes in the South, Appalachia, and Some Tribal Lands
+ Diabetic Eye Disease to Increase
+ Tea is Not Just Good, It’s Good for You
+ Diabetes and Eye Health - Free Eye Exams for Seniors
+ Diabetes, Exercise And Low Blood Sugar



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions